What is the market doing?
What the tape says about HALO
Halozyme Therapeutics, Inc. is +72% over the past year while the S&P 500 is +23%: 50 points ahead of the market.
+72%
1-year return · S&P 500 +23%
- vs 200-day average
- +49%
vs 200-day average · a clear uptrend
- RSI (14)
- 78
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −2.1%
Below its 52-week high
Details›
- Last close2026-08-26
- $107.05
- 1 monthS&P 500 +3.7%
- +32%
- 1 yearS&P 500 +23%
- +72%
- 5 yearsS&P 500 +87%
- +164%
- vs 50-day average$82.93
- +29%
- 52-week high
- $109.30
- 52-week low
- $61.63
- Annualised volatility
- 44%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$2.0M
| Year | Return |
|---|---|
| 2026 (year to date) | +59% |
| 2025 | +41% |
| 2024 | +29% |
| 2023 | −35% |
| 2022 | +42% |
| 2021 | −5.9% |
| 2020 | +141% |
| 2019 | +21% |
| 2018 | −28% |
| 2017 | +105% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +3.2% |
| Feb | 10 | 7 of 10 | +3.5% |
| Mar | 10 | 4 of 10 | −2.7% |
| Apr | 10 | 5 of 10 | +2.3% |
| May | 10 | 5 of 10 | −0.85% |
| Jun | 10 | 7 of 10 | +6.4% |
| Jul | 11 | 8 of 11 | +7.1% |
| Aug | 11 | 7 of 11 | +5.1% |
| Sep | 10 | 3 of 10 | +1.4% |
| Oct | 10 | 3 of 10 | −5.5% |
| Nov | 10 | 8 of 10 | +14% |
| Dec | 10 | 3 of 10 | −0.77% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.